ZUG, Switzerland--(BUSINESS WIRE)--PSI-CRO heartily congratulates the Alchemia team on their success in the “Ride to Conquer Cancer’ which took place in Brisbane, Australia over the weekend of August 18-19. PSI is currently providing clinical trial services for Alchemia’s development of HA-Irinotecan and was delighted to be the team’s main sponsor for the cycling fundraiser.
